Evolent Health, Inc. (EVH)
NYSE: EVH · IEX Real-Time Price · USD
29.62
-0.02 (-0.07%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Evolent Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 192.83 | 188.2 | 266.28 | 319 | 101.01 | 228.32 | 238.43 | 134.56 | 145.73 | 0 | Upgrade
|
Short-Term Investments | 13.77 | 14.49 | 75.69 | 14.37 | 21.89 | 154.72 | 82.4 | 78.76 | 14.15 | 0 | Upgrade
|
Cash & Cash Equivalents | 206.59 | 202.69 | 341.97 | 333.38 | 122.9 | 383.04 | 320.83 | 213.32 | 159.87 | 0 | Upgrade
|
Cash Growth | 1.92% | -40.73% | 2.58% | 171.27% | -67.92% | 19.39% | 50.40% | 33.43% | - | - | Upgrade
|
Receivables | 446.75 | 254.68 | 130.6 | 124.06 | 75.67 | 80.21 | 48.95 | 40.64 | 20.38 | 0 | Upgrade
|
Other Current Assets | 30.33 | 20.68 | 51.39 | 90.21 | 30.24 | 24.72 | 8.4 | 11.01 | 4.21 | 0 | Upgrade
|
Total Current Assets | 683.67 | 478.05 | 523.96 | 547.65 | 228.8 | 487.97 | 378.18 | 264.97 | 184.46 | 0 | Upgrade
|
Property, Plant & Equipment | 90.18 | 136.9 | 131.57 | 144.04 | 157.33 | 73.63 | 50.92 | 31.18 | 12.8 | 0 | Upgrade
|
Long-Term Investments | 21.76 | 16.94 | 18.44 | 13.15 | 147.63 | 22.39 | 4.82 | 8.16 | 46.2 | 37.2 | Upgrade
|
Goodwill and Intangibles | 1,869 | 1,166 | 706.08 | 614.02 | 880.52 | 1,103 | 869.45 | 885.49 | 772.06 | 0 | Upgrade
|
Other Long-Term Assets | 16.15 | 19.84 | 39.41 | 52.84 | 83.73 | 35.14 | 9.33 | 10.04 | 0 | 0 | Upgrade
|
Total Long-Term Assets | 1,997 | 1,339 | 895.5 | 824.05 | 1,269 | 1,234 | 934.52 | 934.87 | 831.05 | 37.2 | Upgrade
|
Total Assets | 2,680 | 1,817 | 1,419 | 1,372 | 1,498 | 1,722 | 1,313 | 1,200 | 1,016 | 37.2 | Upgrade
|
Accounts Payable | 48.25 | 57.17 | 96.08 | 31.98 | 37.49 | 146.76 | 42.93 | 43.89 | 16.7 | 0 | Upgrade
|
Deferred Revenue | 5.98 | 5.76 | 11.94 | 10.19 | 19.83 | 20.58 | 24.81 | 20.48 | 14.84 | 0 | Upgrade
|
Current Debt | 9.74 | 7.12 | 7.07 | 33.91 | 6.27 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Liabilities | 610.28 | 363.39 | 330.4 | 327.22 | 129.18 | 102.01 | 64.96 | 67.57 | 27.97 | 0 | Upgrade
|
Total Current Liabilities | 674.24 | 433.44 | 445.49 | 403.29 | 192.77 | 269.36 | 132.7 | 131.94 | 59.51 | 0 | Upgrade
|
Long-Term Debt | 635.06 | 469 | 273.4 | 325.87 | 362.53 | 221.04 | 121.39 | 120.28 | 0 | 0 | Upgrade
|
Other Long-Term Liabilities | 124.88 | 55.44 | 6.93 | 22.94 | 13.67 | 42.53 | 12.3 | 35.5 | 21.43 | 0 | Upgrade
|
Total Long-Term Liabilities | 759.94 | 524.43 | 280.33 | 348.81 | 376.2 | 263.57 | 133.69 | 155.78 | 21.43 | 0 | Upgrade
|
Total Liabilities | 1,434 | 957.88 | 725.83 | 752.1 | 568.97 | 532.93 | 266.39 | 287.73 | 80.94 | 0 | Upgrade
|
Total Debt | 644.8 | 476.12 | 280.47 | 359.78 | 368.79 | 221.04 | 121.39 | 120.28 | 0 | 0 | Upgrade
|
Debt Growth | 35.43% | 69.76% | -22.05% | -2.44% | 66.84% | 82.09% | 0.92% | - | - | - | Upgrade
|
Retained Earnings | -719.19 | -606.15 | -626.78 | -589.18 | -251.96 | 50.01 | 85.95 | 146.62 | 306.69 | -25.81 | Upgrade
|
Comprehensive Income | -1.26 | -1.18 | -0.36 | -0.28 | -0.23 | -0.18 | 0 | 0 | 0 | 0 | Upgrade
|
Shareholders' Equity | 1,068 | 859.42 | 693.63 | 619.6 | 922.36 | 1,144 | 1,011 | 702.53 | 649.34 | -2.07 | Upgrade
|
Net Cash / Debt | -438.2 | -273.43 | 61.5 | -26.41 | -245.9 | 162 | 199.44 | 93.04 | 159.87 | 0 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | -18.77% | 114.36% | -41.81% | - | - | Upgrade
|
Net Cash Per Share | -3.94 | -2.92 | 0.71 | -0.31 | -2.99 | 2.09 | 3.10 | 2.07 | 3.47 | - | Upgrade
|
Working Capital | 9.43 | 44.61 | 78.47 | 144.36 | 36.03 | 218.61 | 245.48 | 133.03 | 124.96 | 0 | Upgrade
|
Book Value Per Share | 9.60 | 9.17 | 8.06 | 7.30 | 11.20 | 14.79 | 15.71 | 15.60 | 25.84 | -0.90 | Upgrade
|